Dynamic MapReport

World News   USA   California   Bay Area   Genentech   Business   Earnings (21)
Genentech, Earnings Timeline Tuesday, May 1 Bookmark and Share     Author
Search Bay Area News Atlas:

4Q Earnings Soar 75%
World News (13) World Earnings (156) USA (336) California (187) Bay Area (12) Bay Area Earnings (333) Genentech (71) Business Earnings (21)
1st Quarter Earnings (2) 4th Quarter Earnings (2) Cancer Drug Sales (2) Rituxan (2)
2008 (1) 2007 (2) 2006 (4) 2005 (5) 2004 (3) 2003 (2) 2002 (3) 2001 (1)
Earnings on Wikipedia Earnings on Web

South SF Earnings (21)   San Francisco Earnings (59)   Cancer Drug Sales (2)   Profits (67)   South SF Bio Tech (40)
3Q Profit Up 21 % On Cancer Drug Sales
4Q Profit Rises 6 Percent


year 2008 Top ^

Jan.14
  The biotech giant barely scraped past expectations as stock dropped in after-hours trading as sales of a key product also fell below expectations


year 2007 Top ^

Oct.16
  The profit rose nearly 21% from a year ago, beating expectations by a penny thanks to stronger-than-expected sales of the Avastin

Jan.10
  A strong demand for cancer-fighting drugs fueled a profit increase as company executives shook off doubts


year 2006 Top ^

Jul.11 2Q Profit Soars to $531 Million
  The biotechnology company blew past Wall Street expectations with a 79% surge in second quarter earnings
Apr.12 Profit climbs by 48% in first quarter
  Genentech Inc. raised its full-year earnings growth estimate to as much as 55% over 2005 Jan.12 Shares tumble  Shares dropped more than 4% as investors reacted to an earnings report that met analysts' expectations Jan.11 Up 64% in quarter after good year  Earnings per share grew 63 percent to 31 cents as cancer drugs continued to build sales

year 2005 Top ^

Oct.10 Big 3rd Quarter Gains  Genentech Inc. reported a 56% surge in 3rd-quarter net income, fueled by drug sales of its colon cancer drug Jul.11 Profits Soar 73% in 2Q
  The second quarter profit is fueled by continued strong drug sales. The results exceeded the estimate by 4 cents
May.24 Genentech up on drug data  Drug for a eye disease showed that it may stabilize or reverse the condition in a clinical trial Apr.12 Biotech giant's profit up 61%
  The colon cancer drug Avastin and other cancer drugs boost sales Jan.10 Profit surges, misses expectations by 1c  Biotechnology titan reported a 63% surge in its fourth-quarter profits on strong sales of a string of new drugs

year 2004 Top ^

Oct.6 Profits surge on drug sales
  Genentech reported a 52% surge in 3rd-quarter net income, fueled by strong drug sales across its product line Apr.7 Profits surge on brisk cancer drug sales  Biotechnology company yearlong hot streak continued when it reported robust profits for the first quarter Jan.14 Profits surge on strong drug sales  The results, lifted by popular cancer-fighting drugs, beat analysts' expectations

year 2003 Top ^

Oct.8 Biotech titan posts higher profits  Genentech is boosted by continued strong sales of its 2 blockbuster cancer-fighting drugs and a one-time legal settlement Jan.15 Reports continued strong earnings  Profit in the fourth quarter more than doubled, but a $500 million legal setback detracted from an otherwise rosy year

year 2002 Top ^

Aug.15 Ex-employee charged with insider trading  Lei Wang, 32, a former Genentech programmer has agreed to pay $76,000 to settle charges Apr.5 Stock falls  Biotechnology titan warned it is not ready to apply for federal approval to sell the psoriasis drug Xanelim Jan.16 Earnings rise  Biotechnology company nearly tripled its earnings on the sales strength of its two cancer drugs

year 2001 Top ^

Oct.10 Profits rise  3rd quarter profits rose sixfold. The results exceeded expectations. Net income is $42.7 million




Add a favorite (file a bookmark) to Genentech, Earnings Timeline


Please send feedback to: support@mapreport.com

Advertise on Genentech, Earnings Page

XML